Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter Results

Condition

Audience

Topic

Type

Best Practices for Optimizing Impella Use in High-Risk Patients

Prof. Dr. Nikos Werner introduces European best practices for optimizing Protected PCI with Impella heart pumps that were recently published in European Heart Journal Supplements.

Burzotta: Status Quo and Outlook for pMCS Strategies

Francesco Burzotta, MD, discusses the use of percutaneous mechanical circulatory support (pMCS) strategies in both high-risk PCI and cardiogenic shock.

Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice

Vasileios Panoulas, MD, presents 3 patient case examples illustrating significant LV improvement with PCI supported with Impella heart pumps.

Clinical Trial Update with Chuck Simonton, MD

Chuck Simonton, MD, provides an update on clinical trials including PROTECT III, RESTORE EF, and PROTECT IV RCT.

EACTS 2022 on Demand - MCS for PCCS, Structural Heart Disease, and Advanced Cardiogenic Shock

Discover the recordings of our scientific session at EACTS 2022 about "Innovative Strategies for Superior Outcome in Cardiac Surgery Including pMCS Support in Therapy Pathway".

Dr. Junya Ako: J-PVAD Registry and Data Presented at TCT 2022 

Junya Ako, MD, discusses the J-PVAD registry and study data presented at TCT 2022 with Prof. Hermann Reichenspurner.

Dr. Navin Kapur: Cardiogenic Shock Working Group and SCAI Shock Stages–TCT 2022

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

Dr. Navin Kapur: Lessons Learned in STEMI DTU™ Pilot Study–TCT 2022

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

81% Survival at 30 Days in a Multi-Center, Multi-Society Study of  of AMICS Patients Supported With Impella® Heart Pumps in Japan

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan’s J-PVAD study at TCT 2022.

TCT 2022: Data Integrity in Real-World Evidence

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain. Dr.

Case Study Epitomizing Results from RESTORE EF  

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

RESTORE EF Case Study: Contemporary Practices for Impella®-Supported Complete Revascularization

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

Building Collaboration Between Interventionalists and Cardiac Surgeons

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella™.

STEMI-DTU RCT and the Radical, Disruptive Concept of Delayed Reperfusion

Navin Kapur, MD, discusses the latest science underlying reperfusion and unloading and how it led to the STEMI-DTU pilot and pivotal trials.

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].